Cyclerion Therapeutics, Inc. Common Stock
CYCN •
Buy Open
Signal type
Buy
Status
Open
Open Price
$1.50
Stop Loss
$0.86
Performance
114.68%
Days Open
41
Signal Setup
Signal Type Buy
Status Open
Open Date Mar 5, 2026
Open Price $1.50
Stop Loss $0.86
Timespan Day
Company Profile
Name Cyclerion Therapeutics, Inc. Common Stock
Ticker CYCN
Market Cap $11.04M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $3.22
List Date Mar 18, 2019
Description
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
Website Open Company Website